Taiwan FDA registration bbf1ec5b26f40a2337d840e5a7b8503b
"Dr. Len" Ansipine artificial vitreous
TW: “博士倫”安視平人工玻璃體
Taiwan·Risk Class 3·LIFECORE BIOMEDICAL, INC.;; BAUSCH & LOMB INCORPORATED·Registered Jun 01, 2013 – Jun 01, 2028ActiveRegistration details
- Analysis ID
- bbf1ec5b26f40a2337d840e5a7b8503b
- Customs Code
- DHA00602510307
Company information
- Manufacturer Country
- United States
- Authorized Representative
- BAUSCH & LOMB TAIWAN LIMITED
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- M Ophthalmology
- Product Type (Level 2)
- M.4275 眼內充填用液體
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Jun 01, 2013
- Expiry Date
- Jun 01, 2028
About this record
Access comprehensive regulatory information for "Dr. Len" Ansipine artificial vitreous in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number bbf1ec5b26f40a2337d840e5a7b8503b and manufactured by LIFECORE BIOMEDICAL, INC.;; BAUSCH & LOMB INCORPORATED. The authorized representative in Taiwan is BAUSCH & LOMB TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices